Tue, 12 Jan 2010 16:45:21 -0500 PeerView Urology CME/CNE/CPE Video Podcast PVI, PeerView Institute for Medical Education http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2007 PeerView Press,24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://media.peerviewpress.com/000136/podcast/pvi/xml/vidUrologyCME-CNE-CPE_144.jpg PeerView Urology CME/CNE/CPE Video Podcast http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Cardiology no Bernard J. Escudier, MD - Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Treatment for the Right Patient? PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert discusses the latest clinical trial data on targeted therapies for upfront treatment of metastatic RCC, assesses the clinical implications of these data, and provides recommendations for optimal integration of new agents into the current treatment paradigm for advanced RCC. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PPVNE05963s142.m4v Wed, 12 Aug 2009 15:34:59 -0400 Science, Medicine no 00:15:48 renal cell carcinoma, RCC, bevacizumab, sunitinib, sorafenib, interferon, VEGF, TKI, pazopanib, ASCO CME/CNE/CPE Information - Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Treatment for the Right Patient? PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05963CMEinfo.pdf Wed, 12 Aug 2009 15:34:56 -0400 Science, Medicine no 00:00:00 renal cell carcinoma, RCC, bevacizumab, sunitinib, sorafenib, interferon, VEGF, TKI, pazopanib, ASCO Robert J. Motzer, MD - Established and Emerging Therapies for Renal Cell Carcinoma: Clinical Highlights From the 2009 Meeting in Orlando PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in oncology discuss the latest data on current and emerging therapies for advanced renal cell carcinoma. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PA05679FCs545.m4v Wed, 15 Jul 2009 16:01:29 -0400 Science, Medicine no 00:24:00 renal cell carinoma, RCC, AVOREN, CALGB, bevacizumab, interferon, TKI, pazopanib, sunitinib, AV-951 CME/CNE/CPE Information - Established and Emerging Therapies for Renal Cell Carcinoma: Clinical Highlights From the 2009 Meeting in Orlando PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05679FCCMEinfo.pdf Wed, 15 Jul 2009 16:01:23 -0400 Science, Medicine no 00:00:00 renal cell carinoma, RCC, AVOREN, CALGB, bevacizumab, interferon, TKI, pazopanib, sunitinib, AV-951